Abstract
Background: Oral lichen planus (OLP) is a relatively common chronic inflammatory immune-mediated disease affecting the oral mucosa with episodes of exacerbations and remissions. The current study was aimed to compare between the therapeutic outcomes of using low level laser therapy (LLLT) and topical steroids in management of symptomatic OLP and to correlate between the salivary levels of interleukin-6 (IL-6) in in relation to the clinical scores (CS) and pain visual analogue scores (P-VAS) before and after treatment. Subjects and methods: 40 participants were included in this study and were divided into 4 groups of 10 participants each. Group (I) included ten symptomatic atrophic or erosive OLP patients and received topical steroid (triamcinolone acetonide 0.1%). Group (II) comprised also of ten patients having symptomatic OLP and managed with LLLT using 810 nm diode laser. Group (III) included ten patients with asymptomatic reticular OLP. Group (IV) included ten healthy volunteers having no oral or skin lichen planus lesions.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
